Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). This includes both metallic and bioresorbable drug-eluting stents and related clinical trial data.

Bioresorbable stents (BRS) in development presented by Gregg Stone, M.D., during TCT 2017. Several of the players listed on the slider put their BRS development programs on hold after the negative data from the ABSORB III Trial, but a handful of smaller companies are still pushing the technology forward. #TCT #TCT2018

Bioresorbable stents (BRS) in development, presented by Gregg Stone, M.D., during TCT 2017. Several of the players listed on the slider put their BRS development programs on hold after the negative data from the ABSORB III Trial, but a handful of smaller companies are still pushing the technology forward.

Feature | Stents Bioresorbable | October 12, 2018 | Dave Fornell, Editor

Bioresorbable stent (BRS) technology is not dead, but the unbridled enthusiasm seen two years ago for the technology...

Videos | October 11, 2018

A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president,...

The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent. #TCT2018

The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent.

News | Stents | October 04, 2018

October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials...

Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
News | Stents Drug Eluting | October 01, 2018

October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer-...

Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
Technology | Stents Drug Eluting | October 01, 2018

October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its...

Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
News | Stents Drug Eluting | September 26, 2018

September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018...

Orsiro DES Shows Lowest Two-Year Target Lesion Failure in BIO-RESORT Trial
News | Stents Drug Eluting | May 31, 2018

May 31, 2018 — Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-...

OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
News | Stents Drug Eluting | May 29, 2018

May 29, 2018 – Investigators recently unveiled...

Medtronic Begins Bifurcation Cohort of U.S. RESOLUTE ONYX Study
News | Stents Bifurcation | May 29, 2018

May 29, 2018 – Medtronic plc announced the initiation of a U.S....

Abbott's Xience Sierra Stent Receives FDA Approval
Technology | Stents Drug Eluting | May 25, 2018

May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience...

Videos | ACC | March 21, 2018

DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018...

Medtronic Launches 2 mm Onyx DES
Technology | Stents Drug Eluting | February 26, 2018

February 26, 2018 – Designed specifically for small vessels, Medtronic plc announced U.S. Food and Drug...

Overlay Init